Each additional 1,000 daily steps a day may be associated with a reduction in major adverse cardiovascular events among patients with hypertension, with benefits evident at step counts well below 10,000 steps per day.
Large-scale genetic analyses identify multiple susceptibility loci for Takayasu arteritis, confirming HLA-B*52 as the strongest association and revealing immune pathways that vary by ancestry.
Analysis of electronic health records reveals that delays in clinical hypertension diagnosis persist despite frequent outpatient visits and are linked to increased cardiovascular event rates.
Patients with atrial fibrillation undergoing transcatheter mitral repair experience higher rates of heart failure hospitalization and impaired structural recovery compared to those in sinus rhythm.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Researchers found that a lower sodium DASH-style diet tailored for type 2 diabetes reduced blood pressure in adults receiving antihypertensive treatment.
A phase 3 randomized trial found that Moderna’s next-generation COVID-19 vaccine, mRNA-1283, was non-inferior to the earlier mRNA-1273 vaccine in preventing COVID-19 and produced stronger neutralizing antibody responses.
Analysis of U.S. retail health kiosk users reveals that nearly half had high blood pressure, with the highest prevalence among non-Hispanic Black adults.
JAK inhibitor therapy targets inflammation and correlates with improvements in carotid artery measurements, while baseline vascular markers continue to predict cardiovascular risk.